Prevalence and Risk Factors of Metabolic Dysfunction-associated Steatotic Liver Disease

被引：0
|
作者：
Plaza-Aulestia, Nahia [1 ]
Ibarguengoitia-Barrena, Oihane [2 ]
Sampedro-Andrada, Blanca [3 ]
Juan-Lopez, Cristina San [3 ]
Morillo-Montanes, Victoria [4 ]
Urionaguena, Irati [5 ]
Calvo, Itziar [6 ]
Seisdedos, David Montero [7 ]
Vega-Alvarez, Lucia [2 ]
Llorente, Jose Francisco Garcia [2 ]
Revenga, Nuria Vegas [8 ]
机构：
[1] Galdakao Usansolo Univ Hosp, Div Rheumatol, Galdakao, Spain
[2] Galdakao Usansolo Univ Hosp, Div Rheumatol, Bilbao, Spain
[3] Galdakao Usansolo Univ Hosp, Digest Div, Galdakao, Spain
[4] Galdakao Usansolo Univ Hosp, Div Dermatol, Galdakao, Spain
[5] Galdakao Usansolo Univ Hosp, Div Rheumatol, Gernika Lumo, Spain
[6] Hosp Univ Basurto, Bilbao, Spain
[7] Galdakao Usansolo Univ Hosp, Bilbao, Spain
[8] Hosp Galdakao Usansolo, Galdakao, Spain
来源：
ARTHRITIS & RHEUMATOLOGY | 2024年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2321
引用
收藏
页码：4669 / 4671
页数：3
相关论文
共 50 条
  • [1] Genetic Risk Factors for Metabolic Dysfunction-Associated Steatotic Liver Disease
    Pei, Yiying
    Goh, George Boon-Bee
    GUT AND LIVER, 2025, 19 (01) : 8 - 18
  • [2] Overlap prevalence and interaction effect of cardiometabolic risk factors for metabolic dysfunction-associated steatotic liver disease
    Zhao, Dongying
    Zheng, Xiaoyan
    Wang, Liwei
    Xie, Yujie
    Chen, Yan
    Zhang, Yongjun
    NUTRITION & METABOLISM, 2025, 22 (01)
  • [3] Metabolic dysfunction-associated steatotic liver disease prevalence and risk factors in inflammatory bowel disease in tertiary center
    de Oliveira, Livia dos Remedios Pamplona
    Ribeiro, Tarsila Campanha da Rocha
    Mourao-Junior, Carlos Alberto
    Barra, Maria Antonia de Lima
    Silva, Mariana Hippert Gonsalves
    Shafee, Luis Pordeus
    Zacarias, Sarah Mendes
    Campos, Lenilton da Costa
    Valerio, Helena Maria Giordano
    Chebli, Julio Maria Fonseca
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2024, 70 (06):
  • [4] Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease
    Lee, Hyeok-Hee
    Lee, Han Ah
    Kim, Eun-Jin
    Kim, Hwi Young
    Kim, Hyeon Chang
    Ahn, Sang Hoon
    Lee, Hokyou
    Kim, Seung Up
    GUT, 2024, 73 (03) : 533 - 540
  • [5] Cardiovascular Risk Reduction in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis
    Bernhard, Johannes
    Galli, Lukas
    Speidl, Walter S.
    Krychtiuk, Konstantin A.
    CURRENT CARDIOLOGY REPORTS, 2025, 27 (01)
  • [6] Metabolic Dysfunction-Associated Steatotic Liver Disease
    Ali, Sajjadh M. J.
    Lai, Michelle
    ANNALS OF INTERNAL MEDICINE, 2025, 178 (01) : ITC1 - ITC17
  • [7] Identification of Risk Factors Associated with Metabolic Dysfunction-Associated Steatotic Liver Disease in Psoriatic Patients
    Kucuk, Kirley
    Moreno, Christophe
    Nijmi, Hassane
    Daoud, Mathieu
    Mintoff, Dillon
    Willaert, Fabienne
    Benhadou, Farida
    DERMATOLOGY, 2025, 241 (01)
  • [8] Risk factors for hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease
    Liew, Ian Yang
    Phua, Hwee Pin
    Lim, Wei Yen
    Chow, Angela
    Loo, Xiu Ying
    Sim, Kevin
    Lee, Eng Sing
    Yew, Kuo Chao
    JOURNAL OF HEPATOLOGY, 2024, 80 : S497 - S498
  • [9] Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk factors in rheumatoid arthritis
    Saidi, A. N.
    Theel, W. B.
    Burggraaf, B.
    van der Lelij, A. J.
    Grobbee, D. E.
    van Zeben, J. D.
    van der Zwan-van Beek, E.
    Rauh, S. P.
    Cabezas, M. Castro
    CLINICAL RHEUMATOLOGY, 2025, : 1485 - 1492
  • [10] Metabolic dysfunction-associated steatotic liver disease as a cardiovascular risk factor
    Platek, Anna E.
    Szymanska, Anna
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2023, 9 (03) : 187 - 192
12345